Novartis takes aim at Roche’s star MS drug
ZURICH (Reuters) – Swiss drugmaker Novartis on Friday stepped up its challenge to Roche’s multiple sclerosis franchise, highlighting study results for its MS hopeful ofatumumab that could compete with its…
by October Gallery
ZURICH (Reuters) – Swiss drugmaker Novartis on Friday stepped up its challenge to Roche’s multiple sclerosis franchise, highlighting study results for its MS hopeful ofatumumab that could compete with its…
KAMPALA (Reuters) – A nine-year-old girl has died of Ebola in the East African nation of Uganda, a hospital official said, a day after she tested positive for the disease…
GOMA, Democratic Republic of Congo (Reuters) – The death toll from Democratic Republic of Congo’s year-long Ebola outbreak has climbed above 2,000, government data showed on Friday, as responders battle…
(Reuters) – Retrophin Inc said on Thursday it was discontinuing the late-stage study for its rare neurological disorder treatment after it failed to improve patients’ ability to conduct daily activities…
(Reuters) – The U.S. health regulator on Thursday categorized the recall of Edwards Lifesciences Corp’s Sapien 3 Ultra delivery system as extremely serious, highlighting health risks associated with its use,…
LONDON, Aug 23 – Eradicating malaria is biologically feasible and a lofty aim, the World Health Organization said on Friday, but the focus for now should be getting the funds,…
(Reuters) – GlaxoSmithKline said an experimental multiple myeloma treatment has shown a meaningful response in patients that have run out of three previous treatment options, in a boost for the…
GOMA, Congo (Reuters) – Congolese authorities and health workers vaccinated more than 200,000 people against Ebola in August, the government said on Sunday, using a Merck vaccine they hope will…
(Reuters) – The U.S. Centers for Disease Control and Prevention said on Friday it had identified 193 potential cases of severe lung illness tied to vaping in 22 states as…
(Reuters) – Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging the constitutionality of new Canadian regulations meant to lower patented drug prices,…